AlzBiomarker
Control vs Alzheimer's Disease: sAPPβ (Plasma and Serum)
sAPPβ is a secreted peptide produced from APP processing along the "amyloidogenic" pathway. Meta-analysis of three studies did not show a statistically significant difference in the levels of sAPPβ in the plasma of control subjects and people with Alzheimer's disease.
Loading data...